title: Pandoraea bacteremia in a cystic fibrosis patient with associated systemic illness.
abstract: Pandoraea is a recently classified genus primarily isolated from the sputum of cystic fibrosis patients, but its pathogenic potential is unknown. We describe a case of Pandoraea bacteremia in a 16-year-old cystic fibrosis patient associated with clinical disease, suggesting that this organism should be considered a true pathogen in susceptible patients.
authors.affiliation: Department of Pediatrics, University of Washington School of Medicine, Seattle, WA, USA.
authors.forename: Lindsey N
authors.initials: LN
authors.lastname: Johnson
authors.forename: Jin-Young
authors.initials: JY
authors.lastname: Han
authors.forename: Samuel M
authors.initials: SM
authors.lastname: Moskowitz
authors.forename: Jane L
authors.initials: JL
authors.lastname: Burns
authors.forename: Xuan
authors.initials: X
authors.lastname: Qin
authors.forename: Janet A
authors.initials: JA
authors.lastname: Englund
mesh_terms: D000293:Adolescent; D000900:Anti-Bacterial Agents / Q000494:pharmacology; D016470:Bacteremia / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy; D020562:Betaproteobacteria / Q000302:isolation & purification*; D019121:Burkholderia Infections / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy; D003550:Cystic Fibrosis / Q000150:complications / Q000175:diagnosis*; D004359:Drug Therapy, Combination / Q000627:therapeutic use; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008826:Microbial Sensitivity Tests; D012141:Respiratory Tract Infections / Q000150:complications / Q000188:drug therapy / Q000382:microbiology*; D018570:Risk Assessment; D012720:Severity of Illness Index; D016896:Treatment Outcome
chemical_list: D000900:Anti-Bacterial Agents